KAYLA CHUTZ: Open Payments
NPI 1255956934 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,482 in 73 payments from 19 companies in 2025. Trend: 2023 $315 · 2024 $2,542 · 2025 $1,482
Food & beverage: $1,482
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $417 |
| AstraZeneca Pharmaceuticals LP | 11 | $226 |
| PFIZER INC. | 11 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $117 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| ABBVIE INC. | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 4 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
| Exact Sciences Corporation | 2 | $38 |
Products named: Ozempic, Wegovy, ELIQUIS, Kerendia, FARXIGA, LEQVIO, AIRSUPRA, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
